We are live on ! Find out more
PALI icon

Palisade Bio

7 hedge funds and large institutions have $463K invested in Palisade Bio in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

30% less funds holding

Funds holding: 107 (-3)

52% less capital invested

Capital invested by funds: $956K → $463K (-$494K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
3
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$2K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$106K -$572K -14 -82%
Vanguard Group
2
Vanguard Group
Pennsylvania
$74K
ACM
3
Alethea Capital Management
Washington
$73K
William Blair & Company
4
William Blair & Company
Illinois
$39K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$37K
BlackRock
6
BlackRock
New York
$31K
Citadel Advisors
7
Citadel Advisors
Florida
$31K
Renaissance Technologies
8
Renaissance Technologies
New York
$15K
VF
9
Virtu Financial
New York
$15K
Northern Trust
10
Northern Trust
Illinois
$12K
BRWA
11
B. Riley Wealth Advisors
Florida
$6K
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$5K
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$5K
BF
14
BOK Financial
Oklahoma
$4K
Wells Fargo
15
Wells Fargo
California
$3K
CG
16
Cutler Group
California
$2K
CA
17
Centerpoint Advisors
Massachusetts
$1K
Morgan Stanley
18
Morgan Stanley
New York
$1K
OIA
19
OneDigital Investment Advisors
Kansas
$1K
UBS Group
20
UBS Group
Switzerland
$1K
RCAG
21
Rehmann Capital Advisory Group
Michigan
$581
RE
22
RBC Europe
United Kingdom
$7
AC
23
Armistice Capital
New York
-$185K -7 Closed
PAM
24
Panagora Asset Management
Massachusetts
-$17K -1 Closed
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
-$22K -1 Closed

PALI Hedge Fund Activity: Q1 2019 in Review

7 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2019, worth a combined $463K — down 52% from $956K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PALI and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, cutting an estimated $572K.

  • 7 institutional investors held Palisade Bio (PALI) as of Q1 2019, down from 10 in Q4 2018.
  • Funds reported $463K of Palisade Bio stock for Q1 2019, down 52% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q1 2019 and 3 closed out, a net change of -3 holders.
  • The largest Palisade Bio seller in Q1 2019 was Sabby Management, an estimated $572K sold.

Based on aggregated 13F filings for Q1 2019.